Life

Pre-market Movers: EVAX, PETZ, BTTX, QNST, FATBB…

Toyota H1 Profit Climbs; Lifts FY Profit View

Toyota Motor Corp. (TYT.L,TM) reported that its net income attributable to the company for the first half of fiscal year ended September 30, 2021 climbed to 1.52 trillion yen or 109.28 yen per share from 629.37 billion yen or 44.76 yen per share in the same quarter last year.

Operating income rose to 1.75 trillion yen, from 519.98 billion yen in the previous year.

Total sales revenues grew to 15.48 trillion yen, from 11.38 trillion yen last year.

The company declared interim ordinary dividend of 120 yen per share, an increase of 15 yen compared to the previous fiscal year. It has also decided to conduct a repurchase of up to 150 billion yen of common stock.

Consolidated vehicle sales for the period was at 4.94 million, which was 132.7% of consolidated vehicle sales for the first half of the previous fiscal year.
Toyota and Lexus brand vehicle sales was at 4.852 million, which was 121.0% of such sales for the first half of the previous fiscal year.

For the fiscal year ending March 31, 2022, the company now expects Consolidated vehicle sales to be 8.55 million units, which is 98.3% of the previous forecasts. As for Toyota and Lexus brand vehicle sales, the company anticipates that vehicle sales will be 9.4 million units, which is 97.9% of the previous forecasts.

The company now expects annual net income of 2.49 trillion yen, operating income of 2.80 trillion yen. Previously, it expected net income of 2.30 trillion yen, operating income of 2.50 trillion yen.

The company still expects annual sales revenues of 30 trillion yen.

Fujifilm H1 Results Climb, Upgrades FY View; Stock Up

Shares of Fujifilm Holdings (FUJIF.PK,FUJIY.PK) were gaining around 5 percent in Japanese trading after the company reported higher first-half results and upgraded fiscal year outlook.

For the first half, net profit attributable to the company was 96.26 billion yen, up 42.4 percent from 67.61 billion yen last year. Earnings per share were 239.86 yen, up from 168.56 yen a year ago.

Operating income climbed 91 percent from last year to 107.86 billion yen.

Revenue for the period grew 20.8 percent to 1.21 trillion from 997.39 billion yen a year ago.

Looking ahead to the fiscal year 2022, the company now expects attributable net income to decline 3.4 percent to 175 billion yen or 436.65 yen per share. The company previously expected net income of 160 billion yen.

However, operating income is expected to grow 33 percent to 220 billion yen, higher than previous estimate of 200 billion yen. Revenue would grow 14.5 percent to 2.51 trillion yen, compared to previously expected revenue of 2.50 trillion yen.

In Japan, Fujifilm shares were trading at 9,503 yen, up 4.8 percent.

Hikma Reaffirms Segmental Revenue Guidance For FY21

Hikma Pharmaceuticals Plc (HIK), a British multinational pharma company, Thursday said it is reaffirming its guidance for the fiscal 2021, owing to a strong demand for its products and services and a positive momentum in the market.

The London-headquartered company said its Injectables segment is set to move forward with its growth trajectory in the current fiscal, amidst a rise in demand, especially in the U.S. and Europe. It expects its global Injectables revenue to grow in the mid-single digits and core operating margin to be in the range of 37 percent – 38 percent.

Hikma continues to project its full-year Generics revenue to be in the range of $810 million to $830 million and core operating margin to be closer to the top end of its guidance range of 22 percent – 24 percent, reflecting a more favorable product mix.

The British company also said its Branded business is performing well, in-line with its expectations and that it continues to expect Branded revenue growth in constant currency to be in the mid-single digits for 2021.

Opinion | What to Do About Facebook, and What Not to Do

Send any friend a story

As a subscriber, you have 10 gift articles to give each month. Anyone can read what you share.

By Farhad Manjoo

Opinion Columnist

The T List: Six Things We Recommend This Week

Sun-kissed wines from the South of France, musings from Tom Ford — and more.

Send any friend a story

As a subscriber, you have 10 gift articles to give each month. Anyone can read what you share.

ViacomCBS Inc. Q3 Earnings Retreat

ViacomCBS Inc. (VIAC) released a profit for third quarter that declined from the same period last year.

The company’s earnings totaled $538 million, or $0.80 per share. This compares with $615 million, or $1.00 per share, in last year’s third quarter.

Excluding items, ViacomCBS Inc. reported adjusted earnings of $510 million or $0.76 per share for the period.

The company’s revenue for the quarter rose 13.2% to $6.61 billion from $5.84 billion last year.

ViacomCBS Inc. earnings at a glance:

-Earnings (Q3): $510 Mln. vs. $516 Mln. last year.
-EPS (Q3): $0.76 vs. $0.83 last year.
-Revenue (Q3): $6.61 Bln vs. $5.84 Bln last year.

Pre-market Movers: EVAX, PETZ, BTTX, QNST, FATBB…

The following are some of the stocks making big moves in Thursday’s pre-market trading (as of 05.35 A.M. EDT).

In the Green

Evaxion Biotech A/S (EVAX) is up over 166% at $17.30
TDH Holdings, Inc. (PETZ) is up over 89% at $4.50
Better Therapeutics, Inc. (BTTX) is up over 33% at $16.39
QuinStreet, Inc. (QNST) is up over 21% at $16.36
XORTX Therapeutics Inc. (XRTX) is up over 18% at $4.59
Lion Group Holding Ltd. (LGHL) is up over 18% at $2.54
Asensus Surgical, Inc. (ASXC) is up over 14% at $2.11
Artelo Biosciences, Inc. (ARTL) is up over 14% at $1.18
iBio, Inc. (IBIO) is up over 14% at $0.96
Big 5 Sporting Goods Corporation (BGFV) is up over 11% at $35.40
Zomedica Corp. (ZOM) is up over 10% at $0.57
China Xiangtai Food Co., Ltd. (PLIN) is up over 9% at $1.08

In the Red

FAT Brands Inc. (FATBB) is down over 19% at $12.38
Petros Pharmaceuticals, Inc. (PTPI) is down over 14% at $2.47
ION Geophysical Corporation (IO) is down over 12% at $2.31
Immersion Corporation (IMMR) is down over 11% at $8.50
Magnite, Inc. (MGNI) is down over 9% at $24.60